Cargando…
A Military-Centered Approach to Neuroprotection for Traumatic Brain Injury
Studies in animals show that many compounds and therapeutics have the potential to greatly reduce the morbidity and post-injury clinical sequela for soldiers experiencing TBI. However, to date there are no FDA approved drugs for the treatment of TBI. In fact, expert opinion suggests that combination...
Autores principales: | Shear, Deborah A., Tortella, Frank C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679469/ https://www.ncbi.nlm.nih.gov/pubmed/23781213 http://dx.doi.org/10.3389/fneur.2013.00073 |
Ejemplares similares
-
Rethinking Neuroprotection in Severe Traumatic Brain Injury: Toward Bedside Neuroprotection
por: Zoerle, Tommaso, et al.
Publicado: (2017) -
Brain Injury Markers: Where are We?
por: Mondello, Stefania, et al.
Publicado: (2014) -
The Diagnosis of Traumatic Brain Injury on the Battlefield
por: Schmid, Kara E., et al.
Publicado: (2012) -
Subacute Changes in Cleavage Processing of Amyloid Precursor Protein and Tau following Penetrating Traumatic Brain Injury
por: Cartagena, Casandra M., et al.
Publicado: (2016) -
Sinomenine Provides Neuroprotection in Model of Traumatic Brain Injury via the Nrf2–ARE Pathway
por: Yang, Youqing, et al.
Publicado: (2016)